27/03/2025NCIRS webinarTriple protection: Vaccines for influenza, COVID-19 and RSV in 2025 NCIRS webinar series Main navigation Australian Immunisation Handbook COVID-19 vaccines Immunisation coverage data and reports Education and training History of immunisation Immunisation schedules National and international resources NCIRS fact sheets, FAQs and other resources NCIRS webinar series Upcoming – What’s new in pneumococcal vaccination for infants, children and adolescents 25/06/2025 – Navigating vaccination for immunocompromised patients: New Handbook guidance 27/03/2025 – Triple protection: Vaccines for influenza, COVID-19 and RSV in 2025 06/02/2025 – Australian RSV immunisation update – new funded programs for infant protection 10/10/2024 – Falling childhood vaccination rates: current context and future strategies 08/08/2024 – Rabies, travel vaccines and global trends in vaccine-preventable diseases 27/03/2024 – Influenza and COVID-19 vaccination update 07/03/2024 – RSV vaccines for the protection of older adults 27/02/2024 – New RSV vaccine and antibody to prevent disease in infants 07/11/2023 - New shingles vaccine on Australia's NIP 22/09/23 – Vaccination for people with disability 05/05/2023: HPV in 2023 – latest vaccine recommendations and research 16/03/2023: COVID-19 and influenza vaccination update 2023 8/11/2022: Mpox (formerly monkeypox) vaccines 01/09/2022: Emerging vaccine preventable diseases and vaccination for travel 12/05/2022: Preventing shingles (herpes zoster) and its complications using zoster vaccines - and a quick update on COVID-19 vaccines 05/04/2022: Managing seasonal respiratory viruses: Flu and SARS-CoV-2 Winter 2022 03/03/2022: Living with COVID-19: Getting back to immunisation business as usual 8/12/2021: COVID-19 in children and adolescents: vaccines, transmission at school and disease outcomes 13/10/2021: Weighing up the benefits and risks of COVID-19 vaccination: a focus on safety - REGISTER NOW 26/08/21 - What’s next for Australia’s COVID-19 vaccine program? 24/06/2021 - Supporting COVID-19 vaccine access in the Indo-Pacific 30/04/2021: Australia’s COVID-19 vaccine program reset: navigating safety, acceptance and uptake 31/03/21: COVID-19 and 2021 influenza vaccines – the how, what, why and when 17/3/2021: COVID-19 vaccine safety in focus 19/2/2021: Out of the starting blocks: COVID-19 vaccination program in Australia - Part 2 12/02/2021 - Out of the starting blocks: COVID-19 vaccination program in Australia - Part 1 23/11/2020 - SARS-CoV-2 vaccine development: is a finish line in sight? 22/09/2020: Learning together – Transmission of SARS-CoV-2 in NSW educational settings 16/6/2020 - National Immunisation Program changes: what you need to know 17/03/2020 - 2020 influenza program update 18/2/2020 - Measles a local, regional and global perspective 10/12/19 - Working together to improve Aboriginal and Torres Strait Islander immunisation 22/10/19 - Addressing parents’ immunisation communication and information needs and SKAI eLearning module & provider website launch 23/7/19 - HPV vaccination impact: successes and opportunities 4/6/19- Deadly diseases: a history and the current battle against measles 1/5/19 - Protecting our most vulnerable children from influenza: we can do better 20/3/19 - All you need to know about Flu in 2019 plus great new tool to support vaccination in pregnancy 18/2/2019 - Conversations with vaccine-hesitant parents: how the new SKAI website can help 21/11/18 - Australian Immunisation Register & Handbook Update 3/10/18 - Immunisation through an equity lens: New Zealand and global 19/09/18 Vaccine safety and adverse events following immunisation: a practical approach 11/07/18 - National Immunisation Program schedule changes - Your questions answered 31/05/18 Maternal vaccination: The knowns and unknowns 23/4/18 - Active surveillance for immunisation programs 12/03/18 - Influenza prevention and control: We can do better 22/11/17 - Tailoring Immunization Programmes (TIP) 27/09/17 - Addressing vaccine hesitancy and refusal 23/08/17 Varicella Zoster Virus Vaccines 26/07/17 - Tuberculosis & the Bacille Calmette-Guérin (BCG) vaccine 24/05/17 Maternal Immunisation against Pertussis 22/03/17 - A One Health Approach to the Problem of Q Fever 22/2/17 - Pneumococcal vaccines for elderly adults UPCOMING - NCIRS Seminar Series - Tuesday 4 June - Deadly diseases: a history and the current battle against measles Patient communication resources Specialist immunisation services SKAI - supporting health professionals NCIRS newsletters Vaccine safety NCIRS webinar series Main navigation Australian Immunisation Handbook COVID-19 vaccines Immunisation coverage data and reports Education and training History of immunisation Immunisation schedules National and international resources NCIRS fact sheets, FAQs and other resources NCIRS webinar series Upcoming – What’s new in pneumococcal vaccination for infants, children and adolescents 25/06/2025 – Navigating vaccination for immunocompromised patients: New Handbook guidance 27/03/2025 – Triple protection: Vaccines for influenza, COVID-19 and RSV in 2025 06/02/2025 – Australian RSV immunisation update – new funded programs for infant protection 10/10/2024 – Falling childhood vaccination rates: current context and future strategies 08/08/2024 – Rabies, travel vaccines and global trends in vaccine-preventable diseases 27/03/2024 – Influenza and COVID-19 vaccination update 07/03/2024 – RSV vaccines for the protection of older adults 27/02/2024 – New RSV vaccine and antibody to prevent disease in infants 07/11/2023 - New shingles vaccine on Australia's NIP 22/09/23 – Vaccination for people with disability 05/05/2023: HPV in 2023 – latest vaccine recommendations and research 16/03/2023: COVID-19 and influenza vaccination update 2023 8/11/2022: Mpox (formerly monkeypox) vaccines 01/09/2022: Emerging vaccine preventable diseases and vaccination for travel 12/05/2022: Preventing shingles (herpes zoster) and its complications using zoster vaccines - and a quick update on COVID-19 vaccines 05/04/2022: Managing seasonal respiratory viruses: Flu and SARS-CoV-2 Winter 2022 03/03/2022: Living with COVID-19: Getting back to immunisation business as usual 8/12/2021: COVID-19 in children and adolescents: vaccines, transmission at school and disease outcomes 13/10/2021: Weighing up the benefits and risks of COVID-19 vaccination: a focus on safety - REGISTER NOW 26/08/21 - What’s next for Australia’s COVID-19 vaccine program? 24/06/2021 - Supporting COVID-19 vaccine access in the Indo-Pacific 30/04/2021: Australia’s COVID-19 vaccine program reset: navigating safety, acceptance and uptake 31/03/21: COVID-19 and 2021 influenza vaccines – the how, what, why and when 17/3/2021: COVID-19 vaccine safety in focus 19/2/2021: Out of the starting blocks: COVID-19 vaccination program in Australia - Part 2 12/02/2021 - Out of the starting blocks: COVID-19 vaccination program in Australia - Part 1 23/11/2020 - SARS-CoV-2 vaccine development: is a finish line in sight? 22/09/2020: Learning together – Transmission of SARS-CoV-2 in NSW educational settings 16/6/2020 - National Immunisation Program changes: what you need to know 17/03/2020 - 2020 influenza program update 18/2/2020 - Measles a local, regional and global perspective 10/12/19 - Working together to improve Aboriginal and Torres Strait Islander immunisation 22/10/19 - Addressing parents’ immunisation communication and information needs and SKAI eLearning module & provider website launch 23/7/19 - HPV vaccination impact: successes and opportunities 4/6/19- Deadly diseases: a history and the current battle against measles 1/5/19 - Protecting our most vulnerable children from influenza: we can do better 20/3/19 - All you need to know about Flu in 2019 plus great new tool to support vaccination in pregnancy 18/2/2019 - Conversations with vaccine-hesitant parents: how the new SKAI website can help 21/11/18 - Australian Immunisation Register & Handbook Update 3/10/18 - Immunisation through an equity lens: New Zealand and global 19/09/18 Vaccine safety and adverse events following immunisation: a practical approach 11/07/18 - National Immunisation Program schedule changes - Your questions answered 31/05/18 Maternal vaccination: The knowns and unknowns 23/4/18 - Active surveillance for immunisation programs 12/03/18 - Influenza prevention and control: We can do better 22/11/17 - Tailoring Immunization Programmes (TIP) 27/09/17 - Addressing vaccine hesitancy and refusal 23/08/17 Varicella Zoster Virus Vaccines 26/07/17 - Tuberculosis & the Bacille Calmette-Guérin (BCG) vaccine 24/05/17 Maternal Immunisation against Pertussis 22/03/17 - A One Health Approach to the Problem of Q Fever 22/2/17 - Pneumococcal vaccines for elderly adults UPCOMING - NCIRS Seminar Series - Tuesday 4 June - Deadly diseases: a history and the current battle against measles Patient communication resources Specialist immunisation services SKAI - supporting health professionals NCIRS newsletters Vaccine safety Watch our webinar on influenza, COVID-19 and respiratory syncytial virus (RSV) vaccines in 2025.People living in Australia are fortunate to have access to effective vaccines protecting against influenza, COVID-19 and, more recently, respiratory syncytial virus (RSV).Staying informed on the latest recommendations for vaccination is essential for immunisation providers.This webinar provides essential information to support the delivery of Australian Government-funded vaccines protecting against influenza, COVID-19 and RSV, as well as privately funded RSV vaccines for older adults, in 2025.The event, hosted by Professor Kristine Macartney (Director, NCIRS), featured a panel of informed immunisation experts who presented on topics including:recent global and Australian trends in influenza, COVID-19 and RSV epidemiologythe Australian influenza vaccination program in 2025COVID-19 vaccination recommendations for 2025RSV vaccines and recommendations for older adultsthe impact, effectiveness and safety of influenza, COVID-19 and RSV vaccines for older adultspractical tips on delivery and maximising uptake for triple protection. Related NCIRS resourcesInfluenza vaccines – frequently asked questions (FAQs)COVID-19 vaccines: Frequently asked questions (FAQs)Respiratory syncytial virus (RSV): Frequently asked questions (FAQs) Vaccination from community pharmacy – at a glanceCo-administration of vaccines for adults: a guide for immunisation providersNCIRS clinical guidance on RSV immunisation product administration errorsVaccine recommendations for pregnant women – a guide for health professionals Webinar recordings Professor Kristine Macartney – Director, NCIRS Kristine Macartney is a paediatrician and infectious disease specialist. She is a medical graduate of the University of NSW and has over 20 years of experience in vaccinology.She has experience working in the US at the Children’s Hospital of Philadelphia, where she was a founding member of the US Vaccine Education Center. Her Doctorate of Medicine was on rotavirus infection, in particular the mucosal immune response to novel vaccine candidates. She is interested in all aspects of vaccine preventable disease research, particularly policy development, vaccine safety and prevention of viral diseases. She is the Senior Editor of the Australian Immunisation Handbook. Kristine is a Staff Specialist in Infectious Diseases and Microbiology at the Children’s Hospital at Westmead and has a conjoint academic appointment as Professor in the Discipline of Child and Adolescent Health at the University of Sydney. Professor Ian Barr – Deputy Director, WHO Collaborating Centre for Reference and Research on Influenza Ian Barr is currently the Deputy Director of the WHO Collaborating Centre for Reference and Research on Influenza, which was designated in 1992 and is one of seven Collaborating Centres globally. The Centre plays a key role in the national and regional surveillance of human and zoonotic influenza viruses as well as having an active research program. Ian has over 35 years’ experience with academic and commercial organisations, including over 24 years at the Centre. He has authored or co-authored over 300 scientific publications, including more than 250 peer reviewed journal articles, reviews and editorials on various aspects of influenza and RSV. Professor Allen Cheng – Director, Infectious Diseases, Monash Health Allen Cheng is an infectious diseases physician and professor in the School of Clinical Sciences at Monash University. He is a member of the Australian Technical Advisory Group on Immunisation (ATAGI) and the National Respiratory Infections Surveillance Committee. Previously, Allen was Chair of the Advisory Committee for Vaccines (2017–22), Co-Chair of ATAGI (2018–21), Deputy Victorian Chief Health Officer (2020–21) and a member of the Australian Health Protection Principal Committee (2020–22). He is a past president of the Australasian Society for Infectious Diseases (2020–22). Dr Tran Nguyen – Senior Medical Officer, NCIRS Tran Nguyen is a Senior Medical Officer in the Research to Inform Policy team at NCIRS. She also works as a general paediatrician and paediatric infectious diseases physician at Bankstown Hospital and in private practice. Tran is an Adjunct Lecturer at the Sydney Children’s Hospital, UNSW Faculty of Medicine and Health and has extensive experience working in the Specialist Immunisation Clinic. She has been involved in many clinical trials, including vaccine trials. She is a member of the Australasian Society of Infectious Diseases. Ms Denise Lyons – Nurse Practitioner, Kotara Family Practice and PHN HealthPathways Clinical Editor Denise Lyons is a highly experienced nurse with over 40 years in the profession, including 25 years dedicated to primary care. She earned her Bachelor of Science in Nursing in the United States in 1985 and, in 2012, became an endorsed Nurse Practitioner in Australia. Currently, she serves as a primary care Nurse Practitioner in General Practice in Newcastle, where she is committed to delivering high-quality, patient-centered care to improve community health. Passionate about excellence in primary care, Denise actively contributes to advancing the profession as an elected Board Director for the Australian Primary Care Nurses Association, advocating for best practices and better health outcomes. Q&A panel – Dr Jeff (Zhicheng) Wang – Research Fellow/Lecturer, NCIRS Dr Jeff Wang is a Research Fellow at NCIRS, an Adjunct Lecturer at the University of Sydney School of Pharmacy and a practising community pharmacist. He has qualifications and experience in vaccinology, clinical pharmacy, systematic reviews and guideline development. In his role at NCIRS, Jeff undertakes research and systematic reviews that inform clinical guidelines related to immunisation. He leads the implementation of GRADE methods in the development of recommendations in the Australian Immunisation Handbook. Full webinar recording News & events News | 11 September 2025 There’s a new vaccine for pneumococcal disease in Australia. Here’s what to know News | 10 September 2025 Measles in Vietnam: breaking the cycle for good News | 05 September 2025 Australian Vaccinology Course launches with impact News | 28 August 2025 NCIRS Global Health: accelerating immunisation progress across Southeast Asia and the Pacific 9666 views